Financing

Financing Cash Flow

Royalty Pharma Financing Cash Flow increased by 9.0% to -$272.67M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 71.0%, from -$941.30M to -$272.67M.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2017
Last reportedQ1 2026

How to read this metric

Negative values often indicate a company is paying down debt or returning capital to shareholders, while positive values may indicate external financing.

Detailed definition

The net result of all cash inflows and outflows related to financing activities, including debt issuance, debt repayment...

Peer comparison

Highly dependent on the company's current capital structure and lifecycle stage compared to industry peers.

Metric ID: net_cash_from_financing

Historical Data

16 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q1 '25Q2 '25Q4 '25Q1 '26
Value-$224.42M$1.03B-$220.97M-$228.25M-$230.09M-$265.55M-$210.37M-$347.00M-$1.36B-$231.89M-$212.00M$1.16B-$941.30M-$507.81M-$299.60M-$272.67M
QoQ Change+560.9%-121.4%-3.3%-0.8%-15.4%+20.8%-64.9%-291.8%+82.9%+8.6%+645.6%-181.4%+46.1%+41.0%+9.0%
YoY Change-1.7%-122.2%+4.8%-52.0%-490.9%+12.7%-0.8%+433.3%-344.0%-143.9%+71.0%
Range-$1.36B$1.16B
CAGR+5.3%
Avg YoY Growth-57.6%
Median YoY Growth-1.7%
Current Streak3 quarters growth

Frequently Asked Questions

What is Royalty Pharma's financing cash flow?
Royalty Pharma (RPRX) reported financing cash flow of -$272.67M in Q1 2026.
How has Royalty Pharma's financing cash flow changed year-over-year?
Royalty Pharma's financing cash flow increased by 71.0% year-over-year, from -$941.30M to -$272.67M.
What does financing cash flow mean?
The net cash flow generated or used by financing activities.